NextFin News - As digital screen time reaches unprecedented levels globally, South Korean startup Edenlux has announced its strategic entry into the United States market. On January 26, 2026, the company revealed plans to launch its latest vision-training device, Eyeary, via the crowdfunding platform Indiegogo in late March. This move marks a significant expansion for the Seoul-based firm, which has already established a U.S. subsidiary in Dallas, Texas, to handle final assembly and logistics. According to TechCrunch, the Eyeary device is designed to combat digital eye strain—a condition affecting millions of smartphone users—by utilizing a sophisticated system of 144 diopter focal points to exercise the ciliary muscles responsible for ocular focusing.
The launch of Eyeary follows the success of the company’s first-generation product, Otus, which debuted in 2022 across several Asian markets, including Singapore and Japan, generating approximately $10 million in gross revenue. Unlike its predecessor, which featured a bulkier VR-style design, Eyeary adopts a lightweight, glasses-like form factor intended for daily use. The device pairs with a mobile application via Bluetooth, allowing Edenlux to collect user data and employ artificial intelligence to provide personalized training programs and recovery forecasts. Founder and CEO Sung-yong Park, a former military physician who developed the technology after experiencing temporary eye muscle paralysis, aims to position the company as a direct competitor to health-tech giants like Oura, focusing on ocular and auditory wellness rather than cardiovascular metrics.
The timing of this U.S. debut is particularly calculated. By categorizing Eyeary as a "wellness device" under U.S. Food and Drug Administration (FDA) guidelines, Edenlux avoids the lengthy and capital-intensive clinical trial process required for medical-grade diagnostic tools. This regulatory pathway allows the company to market the device for "vision training" and "general eye health," tapping into the lucrative consumer wellness sector. This strategy is essential in the current economic climate, where U.S. President Trump has emphasized domestic manufacturing and streamlined regulatory environments. By establishing a Dallas-based subsidiary for final assembly, Park is not only optimizing the supply chain but also aligning with the "Made in America" sentiment prevalent under the current administration.
From a financial perspective, Edenlux enters the U.S. market with a robust balance sheet, having raised $39 million in Series A funding in 2020 and an additional $60 million in Series B in 2022. The decision to use Indiegogo for the Eyeary launch, despite having significant cash reserves, serves as a dual-purpose marketing and market-validation strategy. It allows the company to build a community of early adopters in the U.S. while gathering localized data to refine its AI algorithms. The digital eye strain market is ripe for disruption; with the average adult now spending over six hours a day on screens, the physiological toll on the ciliary muscle—which remains in a constant state of contraction during close-up viewing—has created a massive, underserved demographic of "digital natives" suffering from premature presbyopia and fatigue.
Looking ahead, the success of Edenlux will likely depend on its ability to transition from a hardware provider to a data-driven platform. Park has already hinted at potential partnerships with tech titans such as Apple or Samsung to integrate Edenlux’s vision-protecting technology directly into mobile ecosystems. As the company rolls out specialized products for conditions like dry eye (Tearmore) and myopia prevention (Lumia) in Asian markets, its U.S. performance will serve as a bellwether for whether consumers are willing to adopt "eye fitness" as a standard part of their daily health regimen. If Eyeary can demonstrate measurable improvements in focus and a reduction in screen-induced headaches, Edenlux may well define a new category of essential consumer electronics in the post-2025 health-tech landscape.
Explore more exclusive insights at nextfin.ai.
